STOCK TITAN

Investment Firm Builds Major Position in Eye Disease Treatment Company Eyenovia

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Avenue Capital Management II has filed a Schedule 13D/A (Amendment No. 3) regarding their holdings in Eyenovia, reporting significant ownership changes through multiple investment vehicles. The filing reveals:

Key Investment Vehicles & Holdings:

  • Avenue Venture Opportunities Fund L.P. owns 174,175 shares (4.0%)
  • Avenue Venture Opportunities Fund II L.P. holds 261,263 shares (5.99%)
  • Avenue Capital Management II L.P. controls 435,438 shares (9.99%)

The funds collectively hold warrants to purchase an additional 250,000 shares at $4.00 per share, though these are subject to a 9.99% beneficial ownership blocker. Total shares outstanding as of June 5, 2025: 4,358,755. Avenue Capital Management II L.P. serves as the manager with sole voting and dispositive power over all securities held by the funds.

Positive

  • Avenue Capital Management II, L.P. has accumulated a significant 9.99% ownership stake in Eyenovia through multiple investment vehicles
  • The investment funds hold warrants to purchase an additional 250,000 shares at $4.00 per share, indicating potential for increased ownership

Negative

  • None.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Aggregate amount owned includes 174,175 shares of common stock held directly by Avenue Venture Opportunities Fund, L.P ("Fund"), but excludes 40,000 shares of common stock issuable upon exercise of a warrant to purchase shares of Issuer's common stock. Such warrant is exercisable at any time at Fund's option at a per share exercise price of $4.00. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Aggregate amount owned includes 261,263 shares of common stock held directly by Avenue Venture Opportunities Fund II, L.P. ("Fund II"), but excludes 210,000 shares of common stock issuable upon exercise of a warrant to purchase shares of common stock. Such warrant is exercisable at any time at Fund II's option at a per share exercise price of $4.00. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Avenue Capital Management II, L.P. is a registered investment adviser and is the manager ("Manager") of each of Fund and Fund II, (the "Funds"). The general partner of each of Fund and Fund II has delegated all management authority to Manager and therefore, Manager has sole voting and dispositive power over all securities of Issuer held by the Funds but disclaims beneficial ownership thereof except to the extent of its pecuniary interest, if any, therein. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Aggregate amount beneficially owned excludes Warrants to purchase an aggregate of 250,000 shares of common stock held by the Funds. (3) Percent of class is based on 4,358,755 shares of Common Stock of Issuer outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Avenue Venture Opportunities Partners, LLC ("AVOP") is the general partner of Fund. AVOP has delegated voting and dispositive power over securities held by Fund to Manager and disclaims beneficial ownership of securities held by Fund, except to the extent of its pecuniary interest, if any, therein. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Avenue Venture Opportunities Partners II, LLC ("AVOPII") is the general partner of Fund II. AVOPII has delegated voting and dispositive power over securities held by Fund II to Manager and disclaims beneficial ownership of securities held by Fund II, except to the extent of its pecuniary interest, if any, therein. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) GL Venture Opportunities Partners, LLC ("GLVOP") is the managing member of AVOP, the general partner of Fund. GLVOP has no voting or dispositive power over securities held by Fund and disclaims beneficial ownership of securities held by Fund, except to the extent of its pecuniary interest, if any, therein. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) GL Venture Opportunities Partners II, LLC ("GLVOPII") is the managing member of AVOPII, the general partner of Fund II. GLVOPII has no voting or dispositive power over securities held by Fund II and disclaims beneficial ownership of securities held by Fund II, except to the extent of its pecuniary interest, if any, therein. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Marc Lasry is the beneficial owner of GLVOP and GLVOPII and therefore is the ultimate beneficial owner of the Funds. Mr. Lasry does not have voting or dispositive power over securities held by the Funds. As more fully described in Item 5, aggregate beneficial ownership by the Reporting Persons is limited to a 9.99% blocker, and the aggregate amount beneficially owned in row 11 and the percentage set forth in row 13 give effect to such blocker for each Reporting Person. (2) Percent of class is based on 4,358,755 shares of Issuer's common stock outstanding as of June 5, 2025.


SCHEDULE 13D


Avenue Venture Opportunities Fund, L.P.
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member, GL Venture Opportunities Partners LLC, Man. Member Avenue Venture Opportunities Partners LLC, Gen. Ptnr.
Date:06/20/2025
Avenue Venture Opportunities Fund II, L.P.
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member GL Venture Opportunities Partners II LLC, Man. Mbr Avenue Venture Opportunities Partners II LLC, Gen. Ptnr.
Date:06/20/2025
Avenue Capital Management II, L.P.
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member of Avenue Capital Management II GenPar, LLC, General Partner
Date:06/20/2025
Avenue Venture Opportunities Partners, LLC
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member of GL Venture Opportunities Partners, LLC, Managing Member
Date:06/20/2025
Avenue Venture Opportunities Partners II, LLC
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member of GL Venture Opportunities Partners II, LLC, Managing Member
Date:06/20/2025
GL Venture Opportunities Partners, LLC
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member
Date:06/20/2025
GL Venture Opportunities Partners II, LLC
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry, Member
Date:06/20/2025
Marc Lasry
Signature:/s/ Andrew Schinder
Name/Title:Andrew Schinder POA for Marc Lasry
Date:06/20/2025

FAQ

How many shares of EYEN does Avenue Capital Management II, L.P. beneficially own as of June 2025?

Avenue Capital Management II, L.P. beneficially owns 435,438 shares of EYEN common stock, representing 9.99% of the outstanding shares. This excludes warrants to purchase an additional 250,000 shares held by its managed funds.

What is the total ownership percentage of EYEN stock held by Avenue Venture Opportunities Fund I and II combined?

Avenue Venture Opportunities Fund L.P. owns 4.0% (174,175 shares) and Avenue Venture Opportunities Fund II, L.P. owns 5.99% (261,263 shares), for a combined ownership of approximately 9.99% of EYEN's outstanding shares as of June 5, 2025.

What warrants does Avenue hold for EYEN stock and at what price?

Avenue holds warrants to purchase a total of 250,000 EYEN shares - specifically, Fund I holds warrants for 40,000 shares and Fund II holds warrants for 210,000 shares. All warrants are exercisable at $4.00 per share at the holder's option.

What ownership restrictions apply to Avenue's holdings in EYEN?

Avenue's aggregate beneficial ownership is limited by a 9.99% blocker provision, which restricts the total ownership across all reporting persons to no more than 9.99% of EYEN's outstanding shares.

How many total outstanding shares of EYEN stock are there as of June 2025?

According to the filing, there are 4,358,755 shares of EYEN common stock outstanding as of June 5, 2025.
Eyenovia Inc

NASDAQ:EYEN

View EYEN Stock Overview

EYEN Rankings

EYEN Latest News

EYEN Latest SEC Filings

EYEN Stock Data

40.27M
5.08M
Medicinal and Botanical Manufacturing
Pharmaceutical Preparations
Link
US
NEW YORK